羚锐制药(600285) - 2019 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 35.89% to CNY 101,014,937.07 year-on-year[11] - Operating revenue rose by 4.41% to CNY 580,637,380.24 compared to the same period last year[11] - Basic earnings per share increased by 38.40% to CNY 0.173 compared to the same period last year[11] - The company reported a net profit excluding non-recurring gains and losses of CNY 89,489,090.77, up 15.59% year-on-year[11] - Total operating revenue for Q1 2019 was CNY 580,637,380.24, an increase of 4.5% compared to CNY 556,130,441.99 in Q1 2018[49] - Net profit for Q1 2019 reached CNY 100,335,566.63, representing a 32.4% increase from CNY 75,807,387.15 in Q1 2018[49] - The total comprehensive income attributable to the parent company for Q1 2019 was CNY 136,412,708.90, compared to CNY 42,331,412.55 in Q1 2018, showing a significant increase[54] Assets and Liabilities - Total assets increased by 11.01% to CNY 3,452,358,709.75 compared to the end of the previous year[11] - The company’s total net assets attributable to shareholders increased by 5.97% to CNY 2,206,507,839.55 compared to the end of the previous year[11] - Total liabilities increased to CNY 1,234,181,830.98 from CNY 1,015,484,475.88, marking a rise of around 22%[40] - Current assets rose to CNY 1,869,087,171.55, up from CNY 1,594,808,168.65, indicating an increase of about 17%[40] - Non-current assets totaled CNY 1,583,271,538.20, up from CNY 1,515,155,611.53, indicating an increase of approximately 4.5%[40] Cash Flow - Net cash flow from operating activities increased by 16.96% to CNY 161,360,731.35 year-to-date[11] - Cash flow from operating activities increased by 16.96% compared to the previous year, attributed to an increase in funds received related to operating activities[25] - The company's cash flow from operating activities for Q1 2019 was CNY 161,360,731.35, an increase from CNY 137,959,509.34 in Q1 2018, representing a growth of approximately 17.0%[58] - The net cash flow from operating activities for Q1 2019 was CNY 204,220,537.28, an increase from CNY 152,808,026.03 in Q1 2018, representing a growth of approximately 33.7%[60] - Total cash inflow from operating activities reached CNY 698,702,762.81, compared to CNY 612,884,281.25 in the previous year, indicating a year-over-year increase of about 14%[60] Shareholder Information - The total number of shareholders at the end of the reporting period was 38,582[18] - The largest shareholder, Henan Lingrui Group Co., Ltd., holds 20.77% of the shares[18] - The company repurchased a total of 6,331,603 shares, exceeding 1% of the total share capital[28] Expenses and Financial Metrics - Financial expenses decreased by 96.42% compared to the previous year, primarily due to an increase in interest income from deposits[21] - Asset impairment losses increased by 49.58% year-on-year, mainly due to an increase in bad debt provisions[21] - Research and development expenses for Q1 2019 were CNY 9,990,073.76, slightly down from CNY 10,517,289.42 in Q1 2018[49] - The company reported a financial expense of CNY 74,839.15, significantly lower than CNY 2,092,751.12 in Q1 2018[49] Other Financial Highlights - The weighted average return on equity increased by 1.40 percentage points to 4.75%[11] - The balance of cash and cash equivalents increased to 801,249,048.03 from 640,026,069.07 year-on-year[30] - Other comprehensive income after tax for Q1 2019 was CNY 35,397,771.83, compared to a loss of CNY 32,004,824.03 in Q1 2018[49] - The company's total assets increased to CNY 3,434,184,623.08, up from CNY 3,048,660,016.57, marking a growth of 12.6%[46] - The company's equity increased to CNY 2,231,335,439.39, up from CNY 2,109,479,004.48, reflecting a growth of 5.8%[46]